Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec departure
confidence 75%
filed 2026-07-07
The filing discloses the resignation of Renger van den Heuvel, who held multiple critical roles: Chief Executive Officer, principal financial officer, principal accounting officer, and Board member. While the filing also mentions the appointment of Ana Rita Coelho as Interim CEO and the appointment of three new directors, the primary event is the departure of the CEO and principal financial/accounting officer. The appointment of an interim replacement and new board members are secondary governance actions responding to the departure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-07
Polar Power issued a convertible promissory note to Mayers Ventures LLC for $250,000 consideration with conversion rights into common stock at a price equal to 90% of the lowest daily VWAP in the 7 trading days prior to conversion. The filing explicitly discloses this under Item 3.02 (Unregistered Sales of Equity Securities), and the convertible structure with a below-market conversion floor and registration rights agreement creates material dilution risk to existing shareholders. The investor also gains board designation rights, indicating a significant capital raise with equity upside.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-07
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing preliminary operating results for Q2 2026 ended June 30, 2026. The filing reports key operational metrics including Consumer Loan Marketplace Volume of $4,259 million for Q2 2026 (47% Q/Q growth, 132% Y/Y growth), exceeding previously issued guidance ranges. This is a standard earnings/operating results disclosure furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
The filing discloses a private placement (PIPE) of 3,608,496 units at $0.582 per unit, raising approximately $2.1 million in gross proceeds. Each unit comprises Series A Convertible Preferred Stock (convertible 1:1 to common stock), warrants to purchase common stock equal to 100% of conversion shares, and subscription rights. The transaction is explicitly exempt from registration under Section 4(a)(2) and Regulation D Rule 506(b), and Item 3.02 confirms unregistered sales of equity securities. This is a classic dilutive private placement raising capital through convertible securities and warrants.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-07-07
The filing discloses that on June 25, 2026, the U.S. District Court for the Southern District of Texas entered a temporary restraining order against the Company following a complaint filed by certain plaintiffs. This is a material litigation event. The filing also references a Nasdaq trading halt imposed on June 8, 2026, which compounds the materiality of the disclosure, though the trading halt itself appears to be a consequence of or related to the underlying legal matter.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-07
Item 5.02
The filing discloses both the retirement of Michael D. Hill as CFO (effective July 27, 2026) and the appointment of David Tamez as interim CFO (effective the same date). While both events occur, the principal action the Board has taken is the appointment of Tamez to fill the CFO role, making exec_appointment the most salient classification. The retirement is contextual background explaining why the appointment was necessary.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-07
Item 3.02
Wheeler Real Estate issued approximately 2.12 million shares of common stock across three tranches in June-July 2026 in exchange for preferred stock held by existing security holders, relying on Section 3(a)(9) exemption. Additionally, the Company issued approximately 739,883 shares cumulatively (275,883 in July 2026 and ~464,000 to date) through redemptions of Series D Cumulative Convertible Preferred Stock, with the conversion price of the 7.00% Subordinated Convertible Notes due 2031 adjusted downward to $0.67 per share, representing a 45% discount and material dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-07
Item 8.01
The filing discloses HomeTrust Bancshares' intention to issue its second quarter 2026 earnings release on July 23, 2026. Although filed under Item 8.01 (Other Events) rather than the typical Item 2.02, the substance is an advance notice of an upcoming earnings release, which is material to investors assessing the company's financial performance and results.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-07
Item 1.01
Oportun entered into a Program Management Agreement with Column National Association on June 30, 2026, establishing a new lending program under which Column originates unsecured personal loans and Oportun provides platform services and can purchase loans. This is a material strategic partnership and operational arrangement that establishes a new revenue and lending channel, but it does not constitute a traditional M&A transaction, debt issuance, or other specifically-named event type. The agreement's four-year initial term with auto-renewal and exclusivity provisions indicate strategic significance to the business.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-07
Item 8.01
Morgan Stanley Capital I Inc. (the Registrant) issued and sold commercial mortgage pass-through certificates on July 7, 2026, totaling $645.5 million in publicly offered certificates plus $66.8 million in privately offered certificates, funded by proceeds from the sale of these securities. This constitutes creation of a new direct financial obligation through issuance of debt-like securities backed by a pool of 70 commercial and multifamily mortgage loans, fitting the debt_issuance category. The transaction is material as it represents a substantial capital raise and creation of significant financial obligations.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-07
EX-99.1
This news release announces a major 2026 exploration and resource definition program at the Springer Tungsten Project, including a 67,000-metre diamond drilling program, re-logging of 18,000 metres of historical core, stockpile evaluation, tailings sampling, geophysical surveys, and metallurgical testing. The program is explicitly designed to advance the project toward a previously announced Q4-2027 production target. This is a material operational and strategic milestone for the company's development of a brownfield tungsten asset, affecting investor assessment of project advancement and near-term production feasibility.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-07-07
Item 8.01
News Corporation discloses daily share repurchase activity under its authorized $1 billion repurchase program, with specific transaction details including 8,977,418 Class A shares and 66,163 Class B shares purchased on 07/07/2026 for approximately $227.5 million in aggregate consideration. Share repurchases constitute a form of capital return to shareholders and are material to investors assessing capital allocation and shareholder value enhancement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-07
Item 5.02
Keith R. Wyche was appointed as a member of the Board of Directors of Internet Sciences, Inc., effective July 1, 2026. This is a clear executive appointment disclosed under Item 5.02. The appointment of a new director with substantial experience (including prior board service at NYSE-listed companies) is material to investors' assessment of the company's governance and leadership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-07
Item 2.02
DigitalOcean issued a press release on July 7, 2026 announcing preliminary, unaudited financial results for Q2 2026, including revenue growth expectations of 29%, record RPO exceeding $800M (up 10X year-over-year), and guidance for aEBITDA margin and non-GAAP EPS at or above the high end of prior guidance. This is a classic earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and growth trajectory.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-07
Item 5.02
Courtney Mather resigned from the Board of Directors effective July 6, 2026. The disclosure centers on a director's departure, not an appointment or compensation arrangement. Board departures are material to investors as they affect governance and oversight structure. The filing explicitly states the resignation is not due to disagreement, but the departure itself remains a material governance event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-07
Item 2.02
Penguin Solutions issued a press release on July 7, 2026 announcing Q3 fiscal 2026 financial results, including record net sales of $479 million (up 48% YoY), record GAAP operating income of $51 million (up 417% YoY), and Q3 GAAP diluted EPS of $0.68 versus $(0.01) in the prior year. The company also raised its full-year fiscal 2026 outlook for both net sales and EPS. This is a classic earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-07
Item 5.02
Kathy Elsesser was appointed to Lazard's Board of Directors effective July 7, 2026, and appointed to the Compensation Committee, succeeding Andrew M. Alper as Compensation Committee Chair. Alper retired from the Board after 13 years of service.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-07
Item 7.01
CuriosityStream announced completion of its acquisition of remaining ownership interests in its German operations from SPIEGEL TV and Autentic. The press release explicitly states this transaction "gives CuriosityStream sole ownership of one of its most important international markets" and describes Germany as "the company's largest and most important non-English-speaking market." This is a material acquisition that consolidates control of a key international business segment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-07
Item 5.02
The filing discloses the election of Cynthia Paul as a Class I director to the Board of Yext, Inc., effective July 7, 2026. While the disclosure includes compensation details (initial RSU grant of $350,000 and annual equity eligibility), the principal action is the appointment of a new director with substantial experience in investment management and prior board service at multiple public companies. This is a clear exec_appointment event.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
Item 3.02
The filing discloses multiple unregistered sales of equity securities (Class E, I, and Y shares) to accredited investors across May, June, and July 2026, both through a distribution reinvestment plan and private placements, totaling approximately $36.7 million in aggregate purchase prices. These transactions are explicitly exempt under Section 4(a)(2) and Regulation D, and the Item 3.02 classification confirms this is a dilutive equity issuance material to investors assessing the company's capital structure and shareholder dilution.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-07
Item 5.02
Steven Dassing resigned as Vice President, Corporate Controller and Principal Accounting Officer effective July 22, 2026. While the filing also discloses that Mr. Coler will assume the Principal Accounting Officer role, the principal disclosed action centers on Dassing's departure from a named executive officer position. The resignation of the Principal Accounting Officer is material to investors as it affects the registrant's financial reporting oversight and internal controls.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-07
Item 2.03
Global Industrial amended its Third Amended and Restated Credit Agreement on June 30, 2026, extending the maturity date from October 19, 2026 to June 30, 2031, materially extending the term of its material credit facility and affecting its capital structure and liquidity profile.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 93%
filed 2026-07-07
Item 1.01
Postal Realty Trust entered into a Second Amended and Restated Credit Agreement on July 2, 2026, expanding its aggregate credit facilities from $555 million to $615 million ($275 million revolving facility and $340 million in term loans) with improved pricing of 30 basis points and extended maturity dates through 2030–2031. The facility includes a $335 million accordion feature and $35 million of new term loans advanced on the closing date.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-07
EX-99.1
This press release announces Phase 4 drill results from the Maestro Project, including significant gold-silver mineralization intercepts (164 metres of 0.72 g/t AuEQ) and expansion of the Prodigy discovery. The disclosure also reports re-assay results from historical drill core identifying additional high-grade gold values across the property. These are material operational/exploration milestones for a mineral exploration company that expand the resource potential and guide future drilling strategy, but do not constitute a discrete financial event (earnings release), M&A activity, or other named event type.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-07-07
Item 1.01
Frontier entered into a binding agreement with Avolon to sell 11 A321neo aircraft at delivery, part of a fleet-rightsizing initiative. While this involves a material definitive agreement (Item 1.01), the transaction is fundamentally a sale of assets (aircraft) rather than a traditional M&A activity, debt issuance, or other specifically-named event type. The sale is material to investors as it affects fleet composition and capital deployment, but does not fit cleanly into `ma_activity` (which typically involves acquisitions, mergers, or changes of control) or other specific categories, warranting classification as `financial_other`.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-07
Item 1.01
Lifeway entered into a Master Security Agreement with CIBC Bank USA providing for up to $22 million in loan advances under an Interim Funding Agreement to finance equipment acquisition, with conversion to a five-year Equipment Guidance Line Note at 1-month SOFR plus 1.65%.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-07
Item 1.01
Aethlon Medical entered into a Securities Purchase Agreement on July 6, 2026, to sell 263,000 shares of common stock, 5,633,009 common warrants, 5,370,009 pre-funded warrants, and 225,320 placement agent warrants in a registered public offering priced at $0.71 per unit, raising approximately $4.0 million in gross proceeds. This dilutive equity issuance materially increases the share count and warrant overhang, affecting existing shareholders' ownership percentages and future earnings per share.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-07-07
Item 8.01
Praxis announced a research collaboration and license agreement with Remagine Labs to develop an iontophoretic transdermal patch for ulixacaltamide delivery, complemented by an equity investment in Remagine. This is a material strategic partnership and product development initiative that expands the company's pipeline and competitive positioning, but does not fit the specific operational categories (workforce reduction, restructuring) or other named event types. The collaboration and equity investment represent a significant operational and strategic commitment to advance the ulixacaltamide franchise.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-07-07
EX-99.1
The exhibit announces that CDT has regained compliance with Nasdaq's minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after receiving a notice on June 30, 2026 that the closing bid price met or exceeded $1.00 per share for 10 consecutive business days. This disclosure directly addresses a delisting risk — the prior non-compliance with the minimum bid price rule — and announces its resolution. The materiality is high because listing status is fundamental to a public company's continued trading and investor access.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-07
Item 1.01
Vivani entered into a definitive Merger Agreement on July 1, 2026, whereby its wholly owned subsidiary Cortigent will merge with ClearOne's merger subsidiary, resulting in Cortigent becoming a wholly owned subsidiary of ClearOne. Vivani shareholders will receive 12,500,000 shares of ClearOne common stock as consideration, subject to financing conditions requiring a $10–15 million capital raise for closing.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-07
Item 8.01
Vivani announced entry into an agreement with Novo Nordisk to evaluate NPM-139, a semaglutide implant candidate, leveraging Vivani's NanoPortal platform technology. This material strategic partnership with a major pharmaceutical company represents significant validation of the company's technology platform and development program.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-07
Item 5.02
Shawn Morris resigned from his position as a member of the Board of Directors and the Compliance Committee, effective immediately on July 6, 2026. This is a clear departure of a director from the registrant. Board composition changes are material to investors as they affect governance and oversight. The filing explicitly states the resignation was not due to disagreement, but the departure itself is the principal disclosed action.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-07-07
Item 8.01
COMPASS Pathways announced positive 26-week Phase 3 trial results (COMP006 Part B) for COMP360 psilocybin in treatment-resistant depression, demonstrating rapid onset and durable efficacy with a favorable safety profile. The company is pursuing a rolling NDA submission and has received an FDA National Priority Voucher, with commercial launch anticipated for end of 2026 or H1 2027.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-07
Item 8.01
The Trust declared and will pay a monthly cash distribution of $0.083641 per certificate on July 10, 2026 to certificateholders of record as of July 9, 2026, with an aggregate total distribution of $6,273,078.12 for the period ending June 30, 2026.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-07
Item 5.02
Carson Heagen, Chief Operating Officer of Expion360 Inc., notified the board of his resignation effective August 1, 2026, due to personal reasons. This is a clear departure of a named executive officer from a material C-suite position, making it a straightforward exec_departure event that would affect a reasonable investor's assessment of the company's leadership and operations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
Item 3.02
Sculptor Diversified Real Estate Income Trust issued 873,952 unregistered shares across two separate issuances (July 1 and June 12, 2026) for approximately $9.8 million in gross proceeds, pursuant to Section 4(a)(2), Regulation D, and/or Regulation S, including direct sales and reinvestment plan distributions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-07
Item 7.01
The company declared distributions to stockholders across six classes of common stock, with net distributions ranging from $0.0619 to $0.0665 per share, payable on or about July 10, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
Item 3.02
Cohen & Steers Income Opportunities REIT issued approximately 1.28 million shares across five share classes on July 1, 2026, raising approximately $15.4 million in aggregate consideration. The shares were sold pursuant to Section 4(a)(2) and Regulation D exemptions from Securities Act registration, which is the hallmark of a private placement. This unregistered equity issuance is dilutive to existing shareholders and material to investor assessment of capital structure and ownership.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-07-07
Item 5.02
H. Charles Maddy, III retired as President of Burke & Herbert Financial Services Corp. and Burke & Herbert Bank & Trust Company effective June 30, 2026. While the disclosure includes compensatory arrangements (severance, accelerated vesting of PRSUs, vehicle transfer, COBRA coverage), the principal disclosed action is the departure of a named executive officer from a senior leadership position. The extensive severance and separation agreement details are ancillary to the core event of his retirement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-07
Item 3.02
North Haven Net REIT sold 3,044,831 common shares for approximately $63.5 million in an unregistered private offering under Section 4(a)(2) and Regulation D Rule 506. This is a classic dilutive equity issuance disclosed under Item 3.02, representing a material capital raise that would affect investor assessment of share dilution and the company's capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-07
Item 7.01
The filing discloses 2Q 2026 earnings considerations and factors affecting quarterly results, with a detailed reconciliation of 1Q 2026 GAAP and adjusted earnings ($4.2B and $8.8B respectively) and estimated impacts on 2Q 2026 results by segment. The exhibit explicitly states the company "currently intends to furnish its 2Q 2026 financial results" on July 31, 2026, and provides forward-looking earnings guidance ranges across business segments. This is a pre-announcement of quarterly financial results under Regulation FD, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 94%
filed 2026-07-06
Item 1.01
Unum Life Insurance Company of America entered into a Master Transaction Agreement with Fortitude Reinsurance Company Ltd. to reinsure $3.8 billion of long-term care statutory reserves (26% of total LTC reserves) on a 100% quota share coinsurance basis, with approximately $5.7 billion in assets and cash to be transferred. The transaction is expected to close in 2026 and materially reduces Unum's closed block footprint and risk profile.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-06
Item 5.02
The disclosure centers on the Compensation and Human Resources Committee's approval of special time-vested RSU grants to two named executive officers (Kevin G. Barth and Charles G. Kim) on July 1, 2026, in connection with succession planning. Each grant represents 44,262 shares with three-year cliff vesting contingent on continued employment. This is a compensatory arrangement for directors/officers under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-06
Item 1.01
Tutor Perini completed the issuance of $400 million in 6.625% Senior Notes due 2033 on July 2, 2026, with proceeds used to redeem existing 11.875% Senior Notes due 2029. This material refinancing activity creates a new direct financial obligation governed by an indenture with Wilmington Trust as trustee.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-06
Item 5.02
The disclosure centers on the Compensation and Human Capital Committee's approval of a special one-time restricted stock unit award of 36,000 shares to Brett A. Cope, the President, CEO, and Chairman. The award is explicitly designed as a compensatory arrangement to incentivize continued service beyond his retirement eligibility date, with backloaded vesting (25% in 2027, 25% in 2028, 50% in 2029) and forfeiture provisions upon early retirement. This is a material executive compensation arrangement requiring 8-K disclosure under Item 5.02(e).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-07-06
Item 1.01
Semtech entered into a new $360 million revolving credit facility and uncommitted incremental term loan facility with Morgan Stanley Senior Funding as administrative agent on July 6, 2026, refinancing and replacing the prior JPMorgan Chase credit agreement.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 45%
filed 2026-07-06
Item 8.01
The disclosure announces that Vishay's 2.25% convertible senior notes due 2030 have become convertible during Q3 2026 because the stock price exceeded 130% of the conversion price for 20 of 30 trading days. While this is technically a notice of conversion eligibility rather than issuance of new debt, the event triggers a potential dilutive equity settlement obligation. The classification is uncertain because the core event—a conversion right becoming exercisable—does not fit neatly into the taxonomy; it is neither a new debt issuance nor a dilutive equity issuance, but rather the activation of an existing convertible instrument's conversion feature. However, debt_issuance is the closest fit among financial event types, as it concerns the terms and settlement mechanics of an existing debt obligation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-06
Item 7.01
Katherine W. Brunelle was named Executive Vice President, Chief Credit Officer effective July 1, 2026, representing a material executive appointment to a senior leadership position. While Ryan A. Smith's transition to Executive Vice President, Commercial Banking is also disclosed, the primary action disclosed is Brunelle's appointment to the chief credit officer role, a key executive position at the bank holding company. The appointment of a senior executive with 20 years of commercial banking and credit experience to lead credit operations is material to investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 8.01
Incyte announced completion of its acquisition of Vega Therapeutics for $1.25 billion upfront plus up to $750 million in sales milestone payments. The acquisition adds VGA039, a Phase 3 monoclonal antibody for von Willebrand disease, to Incyte's hematology portfolio. This is a material M&A transaction involving a substantial cash outlay and a late-stage clinical asset that strengthens the company's pipeline.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 8.01
USPH announced the acquisition of a twelve-clinic physical therapy practice effective July 1, 2026, acquiring a 67% equity interest for approximately $12 million in annual revenue. This represents a material acquisition that expands the company's footprint from 44 to 45 states and is a core M&A activity requiring 8-K disclosure under Item 1.01 or 2.01, even though filed under Item 8.01.
View raw filing on EDGAR →